Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load

NCT01924052
completednot_applicable

Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients

NCT03598075
completednot_applicable

Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)

NCT00687947
completednot_applicable

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

NCT00358839

Clinical Trials (4)

Showing 4 of 4 trials
NCT01924052Not Applicable

CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load

Completed
NCT03598075Not Applicable

Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients

Completed
NCT00687947Not Applicable

Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)

Completed
NCT00358839Not Applicable

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4